Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
about
The role of tumor necrosis factor-alpha and interleukin-1 in the mammalian testis and their involvement in testicular torsion and autoimmune orchitis.TNF polymorphisms modify endotoxin exposure-associated longitudinal lung function declineSignal transduction by tumor necrosis factor mediated by JNK protein kinasesThe tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complexPKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acidTumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisExercise induced adipokine changes and the metabolic syndromeTumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinomaThe seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosisCaveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptorsInhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signalingThe blood-testis barrier and its implications for male contraceptionImpaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient miceDiesel exhaust particles induce the over expression of tumor necrosis factor-alpha (TNF-alpha) gene in alveolar macrophages and failed to induce apoptosis through activation of nuclear factor-kappaB (NF-kappaB)Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber modelThe combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cellsStructure-activity relationship of the p55 TNF receptor death domain and its lymphoproliferation mutants.Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells.Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.Systematic mutational analysis of the death domain of the tumor necrosis factor receptor 1-associated protein TRADD.Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritisA novel role for calcium/calmodulin kinase II within the brainstem pedunculopontine tegmentum for the regulation of wakefulness and rapid eye movement sleep.Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surfaceTumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.TNF alpha and the TNF receptor superfamily: structure-function relationship(s).Soluble tumor necrosis factor alpha receptors in sera from leprosy patients.Phenethyl isothiocyanate upregulates death receptors 4 and 5 and inhibits proliferation in human cancer stem-like cells.Functional switching of macrophage responses to tumor necrosis factor-alpha (TNF alpha) by interferons. Implications for the pleiotropic activities of TNF alpha.Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor linesNeurobiological alterations induced by exercise and their impact on depressive disorders [corrected].The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacologySafety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicityTranscriptional control of viral gene therapy by cisplatinViral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.Genetic regulation of host responses to Salmonella infection in mice.Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line.Proteolytic host cell enzymes in gingival crevice fluid.
P2860
Q21245562-8AE04F31-EAF2-441C-B164-DE7BFED4E357Q23913651-CD399440-DC00-42E2-825B-D016D895F27BQ24308037-2CF6A4CA-D2DB-49FA-87EF-5D60FD295B5CQ24323338-86D269EC-491D-4F61-92CF-B2202B12D630Q24568285-B254B399-3CAF-459B-BCD4-B4550D2853F5Q24642851-BE3C21F3-6231-407C-BAF0-31CD5401AB8EQ24682686-BD91D551-B929-46F1-A474-792FE7F59137Q26822992-F6031C1E-2699-4090-B289-6CE88B581B15Q27007477-B8336CF2-01F8-4960-9F99-A542768D9E5EQ28117534-07BDD808-7EF9-49E7-954B-8F633E863CFDQ28139933-3DABE1A3-CEF5-4B4B-BBFA-0B51D8A2DC3CQ28140492-EE3F4A93-A87A-4D3E-86FF-0CCFDF41ABD4Q28395237-015D045E-A6D8-4888-A631-7AF33AE4C940Q28513992-3D92E0E5-5EC5-482D-9717-16E8D4BA8824Q28661903-781E0BD0-47D1-4ADB-84FB-19C56E968910Q30175435-2E70B307-3D8E-4DEB-A00C-7EB920C0F517Q30427978-9D2D21FA-B0C6-424B-8072-7D9BDC594B81Q30486856-C260E2F8-2C85-4B2B-99F6-EDBA3AA86BA1Q32081421-D7382D76-E192-4509-9C50-F7CF8E655D83Q32162146-2FE0D42C-1E12-40E7-AD3D-B4BE15C0FCA2Q33181838-245332D0-BAC9-4AF9-AAA4-BA336DEB3BCEQ33292436-AA2D692E-1470-4753-BB35-01111FF6AFF9Q33575384-E00BC07C-7B0C-4EF7-9E69-0D5B0BDDF1EBQ33578865-05A984FA-ADB4-422A-8F46-B754202164C8Q33601704-25108586-1DC6-4109-93AC-324F2144EB27Q33848147-BD3F1CBE-E514-45A7-841E-5934C06C6DB7Q33899892-4769250D-AA6F-4AA7-8D11-81C7E7D72338Q33909217-38C3DF98-B9A3-42B2-BE43-C3370CFB8198Q34000080-9251C3AB-7A13-4039-A532-949D40DC6E97Q34106016-541F3846-0330-41F4-917C-B22DB9C5776EQ34140551-39AD0FC6-F319-4BEA-9119-C43755F9C002Q34381306-EE639B3C-98D4-4238-BE00-A735257DAEC8Q34517902-8AEFA357-A55E-489D-AD14-09D0CB1CAF4EQ34608619-6EF99ADD-9380-43C6-9914-57D82A0D1FB2Q34701747-B9DDBEBC-1E65-47B5-985C-FA7FC6502C46Q34795177-E9162324-B898-4767-9425-DE38851A7C09Q34857689-ECC6608C-B781-4067-9C4A-407F95361E34Q34993039-853DCE9E-0722-477E-8039-0494025E8CA0Q35083839-2AAF0C25-2FCA-4CF6-A52C-8C48294AEB1FQ35092086-39A260B7-4196-4823-9675-781430EC7E68
P2860
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@ast
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@en
type
label
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@ast
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@en
prefLabel
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@ast
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@en
P1433
P1476
Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
@en
P2093
P304
P356
10.1016/0014-5793(91)80803-B
P407
P577
1991-07-01T00:00:00Z